Asher Herzog focuses his practice on the representation of both issuers and underwriters on a variety of capital markets transactions, including initial public offerings and other equity offerings, high-yield, investment-grade and convertible debt offerings. Asher also regularly counsels publicly traded companies on general corporate matters, including SEC reporting and corporate governance. 

Download full bio 

Experience

  • Centessa Pharmaceuticals – $380 Million IPO 

  • Kadmon Holdings – $240 Million Convertible Notes Offering 

  • Billtrust to Combine With South Mountain, a Special Purpose Acquisition Company, at $1.3 Billion Value 

  • Orphazyme – $84 Million IPO 

  • Dyne Therapeutics – $268 Million IPO 

  • View all

Education

  • Harvard Law School
    JD, 2016

  • Touro College
    BS, Finance
    2013


Admissions & Credentials

New York